MedPath

Adapted High-Intensity Virtual Reality Exergaming

Not Applicable
Not yet recruiting
Conditions
Cerebral Palsy
Registration Number
NCT07155213
Lead Sponsor
University of Alabama at Birmingham
Brief Summary

This study will test the acceptability and benefits of a home-based high-intensity virtual reality exercise program for young people with physical disabilities. The program will last 6 weeks. There will be a total of two visits to the laboratory for exercise-related health assessments. The program includes head-mounted displays (Meta Quest) and off-the-shelf games.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
4
Inclusion Criteria
  • overweight or obese (based on CDC body mass index normative ranges for age and sex)
  • physically inactive (<150 min/week of moderate exercise)
  • Gross Motor Function Classification System level (GMFCS) levels I-IV
  • Physician clearance to participate
  • Wifi internet access at home
Exclusion Criteria
  • Complete blindness or deafness
  • GMFCS level V
  • Unable to communicate in English
  • Prone to photosensitive seizures
  • Pregnant (due to radiation from a Dual Energy X-ray Absorptiometry [DXA] scan

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Total lean massweek 0, week 7

lbs

Total fat massWeek 0, Week 7

lbs

Systolic blood pressureWeek 0, week 7

mmHg

hemoglobin A1c (HbA1C)Week 0, week 7

mmol/mol

high sensitivity C-reactive protein (hsCRP)Week 0, Week 7

mg/L

fasting insulinWeek 0, week 7

μIU/mL

Total cholesterolWeek 0, week 7

mg/dL

Low-density lipoproteinWeek 0, week 7

mg/dL

High-density lipoproteinWeek 0, week 7

mg/dL

Diastolic blood pressureWeek 0, week 7

mmHg

Secondary Outcome Measures
NameTimeMethod
Peak oxygen consumption (pVO2)Week 0, Week 7

mlkg/min

Total work outputWeek 0, Week 7

watts

Resting heart rateWeek 0, week 7

beats/min

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.